Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
06/2010
06/29/2010US7744910 Compounds and compositions for delivering active agents
06/29/2010CA2415280C Use of halogenated xanthenes as anti-cancer and anti-bacterial agents
06/29/2010CA2382885C Rhodamine derivatives for photodynamic diagnosis and treatment
06/24/2010US20100160645 Poly(ethylene glycol) containing chemically disparate endgroups
06/24/2010US20100160632 Bisamid-zinkbasen
06/24/2010US20100160426 Crystalline genistein sodium salt dihydrate
06/24/2010US20100160425 Anti-allergic agent and beverage/food, preparation for external application or cosmetic comprising the agent
06/24/2010US20100160410 Use of pentadienoic acid derivatives for the treatment of hyperuricemia
06/24/2010US20100160268 Isoflavonoid Analogs and their Metal Conjugates as Anti-Cancer Agents
06/24/2010US20100160263 7,9-substituted tetracycline compounds
06/24/2010DE102009058906A1 Photochrome Naphthopyrane mit Verbrückung zweier aromatischer Teilsysteme Photochromic naphthopyrans with bridging of two aromatic subsystems
06/23/2010EP2199289A1 Biologically active extract from Dendrobium plant, use thereof and process for preparing the same
06/23/2010EP2198862A1 Use of flavonoids to treat parasitic infection
06/23/2010EP2197271A2 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
06/23/2010EP1553911B1 2-heterosubstituted 3-aryl-4-h-1-benzopyran-4-ones as novel therapeutics in breast cancer
06/23/2010EP1511734B1 Compounds, compositions, and methods
06/23/2010CN1974527B Process of preparing high purity chlorogenic acid and flavonid with eucommia leaf
06/23/2010CN1821236B Therapeutic heterocyclic compounds
06/23/2010CN101754960A Tetrahydropyranochromene gamma secretase inhibitors
06/23/2010CN101750894A Colored photosensitive resin composition
06/23/2010CN101747310A Compound and chemically amplified resist composition containing the same
06/23/2010CN101747309A Fluoro-alkyl terphenyl liquid crystal compound with sidewise difluoro methylene ether bridged bond as well as preparation method and application thereof
06/23/2010CN101747308A Molecular modification method for enhancing biological activity of procyanidine
06/23/2010CN101747307A Glycyrrhizic acid removal glycyrrhiza flavonoid and medicament composition thereof
06/23/2010CN101747306A Substituent ether compound and application thereof
06/23/2010CN101747305A Five crystal forms of nicousamide compound and preparation method, pharmaceutical composition and usage thereof
06/22/2010US7741456 Polyketides and antibiotics produced by combinatorial techniques
06/22/2010US7741365 Dibenzo[b,d]pyran-6-ones used for providing a physiological effect to treat pain, pain associated with cancer, chemotherapy, neuropathy, Multiple Sclerosis, Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and inflammation; antinociceptive agents
06/22/2010US7741350 Bicyclic pyrazolo-heterocycles
06/22/2010CA2443431C Process for the preparation of isoflavones
06/17/2010WO2010067627A1 Precursor for acid-dissociable dissolution-inhibitive group and cyclic compound having acid-dissociable dissolution-inhibitive group
06/17/2010WO2010067599A1 Process for efficiently producing alkylated catechin
06/17/2010WO2010067078A2 3,6-disubstituted xanthylium salts as medicaments
06/17/2010WO2010066071A1 Process for preparing a photochromic polymeric composition, thus obtained polymeric composition and use thereof
06/17/2010US20100152284 Prevention and reversal of chemotherapy-induced peripheral neuropathy
06/17/2010US20100152283 Tetrahydrocannabinol modulators of cannabinoid receptors
06/17/2010US20100152272 Functionalized drugs and polymers therefrom
06/17/2010US20100151583 Solid phase extraction of ochratoxins
06/17/2010US20100151508 Compounds
06/17/2010US20100151379 Compound and chemically amplified resist composition containing the same
06/17/2010CA2745203A1 3,6-disubstituted xanthylium salts
06/17/2010CA2664445A1 Aromatic ether-containing spirofluorenexanthene monomers, methods for their preparation and polymerization thereof
06/16/2010EP2196463A1 Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof
06/16/2010EP2195308A2 Antiinfective flavononol compounds and methods of use thereof
06/16/2010EP1651958B1 Novel chemiluminescent compounds and their use
06/16/2010CN1970558B lactic acid base puerarin derivative preparation method
06/16/2010CN1780827B Process for the manufacture of tocyl and tocopheryl acylates
06/16/2010CN101735193A 9-anthranone spiro lactone compound and preparation method and application thereof
06/16/2010CN101735192A Method for producing propantheline bromide intermediate Xanthene-9-carboxylic acid
06/16/2010CN101735191A Method for preparing flavonoid component capable of stopping nitrosation reaction
06/16/2010CN101735190A Method for preparing baicalein
06/16/2010CN101735189A Preparation method, preparation and application of tricin
06/16/2010CN101735188A Method for synthesizing brown cyanidin, hispidulin and herba lycopi flavone
06/16/2010CN101735187A Method for extracting coumarin compound from willow leaf calyx canthus
06/16/2010CN101735186A Synthetic process of auraptene and marmin
06/16/2010CN101732440A Raspberry extract and raspberry element obtain by separation thereof and application thereof
06/16/2010CN101200460B Dihydrobenzopyrans ketone compound and uses thereof
06/16/2010CN101086002B Method for hydrolyzing soybean isoflavone by enzyme
06/10/2010WO2010065484A1 Polymer composition and dialysis membrane formed from the polymer composition
06/10/2010WO2010065393A1 Photochromic compounds
06/10/2010WO2010065024A1 Topical treatment of cataracts in dogs
06/10/2010WO2010064817A2 Novel coumarin-based compounds, preparation method thereof, and multidrug resistance inhibitory pharmaceutical compositions containing same as active ingredients
06/10/2010WO2010022520A8 Improved synthesis of hexahydrodibenzopyranones
06/10/2010US20100145078 Solvent addition and removal in the hydrogenation of catmint oil
06/10/2010US20100145077 Hydrogenation of catmint oil
06/10/2010US20100145056 Acetyl 2-hydroxy-1,3-diaminoalkanes
06/10/2010US20100144860 Transglutaminase Inhibitor Comprising EGCG And A Method For Producing Thereof
06/10/2010US20100144857 Prenylflavanone compounds and uses thereof
06/10/2010US20100144856 Prenylfavanone compounds and uses thereof
06/10/2010US20100144729 Coumarin derivatives
06/10/2010CA2745764A1 Photochromic compounds
06/10/2010CA2745612A1 Polymer composition and dialysis membrane formed from the polymer composition
06/09/2010EP1270004B1 Use of gamma-tocotrienol as diuretic
06/09/2010CN101730689A 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators
06/09/2010CN101723938A Synthesis processes and bioactivities of 3-aromatic (hetero)-6,8-dyhydroxy isoflavonoid compounds
06/09/2010CN101723927A Method for batch production, separation and purification of catechin monomers EGCG
06/09/2010CN101723926A Isoflavone derivative and preparation method and application thereof
06/09/2010CN101723925A Preparation method of 7-hydroxy-4-methylcoumarin
06/09/2010CN101723924A Method for preparing coumarin-3-ethyl formate
06/09/2010CN101723768A Method for carrying out hydroxyethylation on phenolic acid compounds and products thereof
06/09/2010CN101220039B Chiral center aza ring carbene precursor salt with camphor framework, synthesizing method and uses thereof
06/09/2010CN101119989B Chroman derivatives and uses thereof in treating CNS disease
06/08/2010US7732625 Metallized dye
06/08/2010US7732161 fermentation method that converts hydroxymethylglutaryl-CoA to L-mevalonic acid and eventually to isoprenoids (farnesol and geranylgeraniol )
06/08/2010CA2492831C Color-stable, low impurity tocopherol compositions and processes for preparing the same
06/03/2010WO2010062506A2 Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors
06/03/2010WO2010060387A1 The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof
06/03/2010WO2008151303A8 Long wavelength fluorogenic intercellular ion indicators
06/03/2010US20100137431 Use of substances that act as cascade inhibitors of the raf/mek/erk signal cascade, for producing a medicament to treat dna and rna viruses
06/03/2010US20100137425 Inhibition and treatment of prostate cancer metastasis
06/03/2010US20100137422 Novel phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome
06/03/2010US20100137421 Small molecule therapeutics, synthesis of analogues and derivatives and methods of use
06/03/2010US20100137360 Trpv1 antagonists
06/03/2010US20100137345 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
06/03/2010US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
06/03/2010US20100137251 Functional Role for Cannabinoids in Autonomic Stability During Sleep
06/03/2010US20100137194 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism
06/03/2010US20100135906 In vivo imaging of sulfotransferases
06/03/2010CA2744828A1 Five crystal forms, methods of preparation, pharmaceutical compositions and applications of 3-(3'-carboxy-4'-hydroxy-anilino-carbo-)-6-nitro-7-hydroxy-8-methyl-coumarin)>>
06/03/2010CA2739251A1 Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 242